TICALIX®

Brand name: Arena Life Science

Generic Name: Ticagrelor

Ticagrelor and its major metabolite reversibly interact with the platelet P2Y12 ADP-receptor to prevent signal transduction and platelet activation. Ticagrelor and its active metabolite are approximately equipotent

Pharmaceutical Class: Antiplatelet agent

Dosage Form and Strength: Tablet, Oral (60 mg ,90 mg)

Product Description:

Indications:

  • Patients with acute coronary syndrome (ACS) or a history of myocardial infarction
  • Patients with coronary artery disease (CAD) at high risk for ischemic events
  • Patients with acute ischemic stroke (NIHSS ≤5) or high-risk transient ischemic attack (TIA)
  • Ticalix® is produced at a GMP approved manufacturing site

Additional Information

Additional information

Related Products

TICALIX®

View Product

Product Images

TICALIX-2 TICALIX-3 TICALIX-2